| 1 |
Polk DB, Peek RM Jr. Helicobacter pylori: gastric cancer and beyond[J]. Nat Rev Cancer, 2010,10(6): 403-414.
|
| 2 |
Hoption Cann SA, van Netten JP, van Netten C. Dr William Coley and tumour regression: a place in history or in the future [J]. Postgrad Med J, 2003,79(938): 672-680.
|
| 3 |
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer [J]. Cell, 2010,140(6): 883-899.
|
| 4 |
Coussens LM, Werb Z. Inflammation and cancer [J]. Nature, 2002,420(6917): 860-867.
|
| 5 |
Karin M, Greten FR. NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol, 2005, 5(10):749-759.
|
| 6 |
Goodwin AC, Destefano CE, Wu S, et al. Polyamine catabolism contributes to enterotoxigenic. Bacteroides fragilis-induced colon tumorigenesis [J]. Proc Natl Acad Sci U S A, 2011,108(37):15345-15359.
|
| 7 |
Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions [J]. J Carcinog, 2006,5:14.
|
| 8 |
Buti L, Spooner E, Van der Veen AG, et al. Helicobacterpylori cytotoxin-associated geneA (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host [J]. Proc Natl Acad Sci U S A, 2011,108(22): 9238-9243.
|
| 9 |
Preuss I, Hildebrand D, Orth JH, et al. Pasteurella multocida toxin is a potent activator of anti-apoptotic signalling pathways [J]. Cell Microbiol, 2010,12(8):1174-1185.
|
| 10 |
Jinadasa RN, Bloom SE, Weiss RS, et al. Cytolethal distending toxin:a conserved bacterial genotoxin that blocks cell cycle progression,leading to apoptosis of a broad range of mammalian cell lineages[J].Microbiology, 2011,157(Pt 7):1851-1875.
|
| 11 |
Abdulamir AS, Hafidh RR, Abu Bakar F. The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role [J].J Exp Clin Cancer Res,2011,30:11.
|
| 12 |
Sears CL. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes [J]. Clin Microbiol Rev, 2009,22(2):349-369.
|
| 13 |
Rhee KJ, Wu S, Wu X, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice [J]. Infect Immun, 2009,77(4):1708-1718.
|
| 14 |
Buc E, Dubois D, Sauvanet P, et al. High prevalence of mucosaassociated E. Coli producing cyclomodulin and genotoxin in colon cancer [J]. PLoS One, 2013,8(2):e56964.
|
| 15 |
Cuevas Rammos G, Petit CR, Marcq I, et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells [J]. Proc Natl Acad Sci U S A, 2010,107(25):11537-11542.
|
| 16 |
Cougnoux A1, Dalmasso G, Martinez R, et al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescenceassociated secretory phenotype [J]. Gut, 2014, Epub ahead of print
|
| 17 |
Uronis JM, Muhlbauer M, Herfarth HH, et al. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility [J]. PLoS One, 2009,4(6):e6026.
|
| 18 |
Kitajima S, Morimoto M, Sagara E, et al. Dextran sodium sulfateinduced colitis in germ-free IQI/Jic mice [J]. Exp Anim, 2001,50(5):387-395.
|
| 19 |
Shen XJ, Rawls JF, Randall T, et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas[J]. Gut Microbes, 2010,1(3):138-147.
|
| 20 |
Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome [J]. Nature, 2013,499(7456):97-101.
|
| 21 |
Kurkivuori J, Salaspuro V, Kaihovaara P, et al. Acetaldehyde production from ethanol by oral streptococci [J]. Oral Oncol, 2007,43(2):181-186.
|
| 22 |
Mager DL, Haffajee AD, Devlin PM, et al. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects [J]. J Translational Med, 2005,3:27.
|
| 23 |
Farrell JJ, Zhang L, Zhou H, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer [J].Gut, 2012,61(4):582-588.
|
| 24 |
Engberts MK, Verbruggen BS, Boon ME, et al. Candida and dysbacteriosis: a cytologic, population-based study of 100,605 asymptomatic women concerning cervical carcinogenesis [J]. Cancer,2007,111(5): 269-274.
|
| 25 |
汪万英, 赵芳芳, 何杰, 等. p53、p16和细菌L型DNA在卵巢肿瘤中的表达及意义[J].中国微生态学杂志, 2005,17(5): 359-361.
|
| 26 |
Wei MQ, Ellem KA, Dunn P, et al. Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours[J]. Eur J Cancer, 2007,43(3): 490-496.
|
| 27 |
Baban CK, Cronin M, O'Hanlon D, et al. Bacteria as vectors for gene therapy of cancer [J]. Bioeng Bugs, 2010,1(6): 385-394.
|
| 28 |
Cronin M, Akin AR, Collins SA, et al. High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting [J].PLoS One, 2012,7(1): e30940.
|
| 29 |
周易明, 刘常星, 邬剑华, 等. 减毒鼠伤寒沙门氏菌作为肿瘤基因治疗载体的低毒性和靶向性研究[J]. 复旦学报(医学版), 2008,35(3): 336-341.
|
| 30 |
Leschner S, Westphal K, Dietrich N, et al. Tumor invasion of Salmonella enterica serovar typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha [J]. PLoS One, 2009,4(8):e6692.
|
| 31 |
Leschner S, Deyneko IV, Lienenklaus S, et al. Identification of tumorspecific Salmonella Typhimurium promoters and their regulatory logic [J]. Nucleic Acids Res, 2012,40(7): 2984-2994.
|
| 32 |
Gravekamp C, Paterson Y. Harnessing Listeria monocytogenes to target tumors [J]. Cancer Biol Ther, 2010,9(4): 257-265.
|
| 33 |
Saccheri F, Pozzi C, Avogadri F, et al. Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity [J].Sci Transl Med, 2010,2(44): 44ra57.
|
| 34 |
Srikanth CV, Wall DM, Maldonado Contreras A, et al. Salmonella pathogenesis and processing of secreted effectors by caspase-3 [J].Science, 2010,330(6002): 390-393.
|
| 35 |
dos Santos SA, de Andrade Júnior DR, de Andrade DR. TNF-α production and apoptosis in hepatocytes after Listeria monocytogenes and Salmonella Typhimurium invasion [J]. Rev Inst Med Trop Sao Paulo, 2011,53(2): 107-112.
|
| 36 |
Ganai S, Arenas RB, Sauer JP, et al. In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis[J]. Cancer Gene Ther, 2011,18(7): 457-466.
|
| 37 |
Zhao M, Suetsugu A, Ma H, et al. Efficacy against lung metastasis with a tumor-targeting mutant of Salmonella typhimurium in immunocompetentmice[J]. Cell Cycle, 2012,11(1): 187-193.
|
| 38 |
Nagakura C, Hayashi K, Zhao M, et al. Efficacy of a geneticallymodified Salmonella typhimurium in an orthotopic human pancreatic cancer in nudemice [J]. Anticancer Res, 2009,29(6): 1873-1878.
|
| 39 |
Momiyama M, Zhao M, Kimura H, et al. Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model [J]. Cell Cycle, 2012,11(3): 628-632.
|
| 40 |
Hayashi K, Zhao M, Yamauchi K, et al. Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium [J]. Cell Cycle, 2009,8(6): 870-875.
|
| 41 |
Shao C, Yang B, Zhao L, et al. Tumor suppressor gene RBM5 delivered by attenuated Salmonella inhibits lung adenocarcinoma through diverseapoptotic signaling pathways[J]. World J Surg Oncol,2013, 11: 123.
|
| 42 |
Jellbauer S, Panthel K, Hetrodt JH, et al. CD8 T-cell induction against vascular endothelial growth factor receptor 2 by Salmonella for vaccination purposesagainst a murine melanoma [J]. PLoS One, 2012,7(4): e34214.
|
| 43 |
Sorenson BS, Banton KL, Augustin LB, et al. Antioxidant oils and Salmonella enterica Typhimurium reduce tumor in an experimental model of hepaticmetastasis [J]. Onco Targets Ther, 2011,4:59-69.
|
| 44 |
Jiang Z, Zhao P, Zhou Z, et al. Using attenuated Salmonella typhi as tumor targeting vector for MDR1 siRNA delivery [J]. Cance Gene Ther, 2007, 6(4): 555-560.
|
| 45 |
Jeong JH, Kim K, Lim D, et al. Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium [J]. PLoS One, 2014,9(1): e80050.
|
| 46 |
Fraillery D, Baud D, Pang SY, et al. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccineagainst cervical cancer and typhoid fever [J]. Clin Vaccine Immunol, 2007,14(10): 1285-1295.
|
| 47 |
Jia Y, Yin Y, Duan F, et al. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse modelInt[J]. J Mol Med, 2012,30(6): 1335-1342.
|
| 48 |
Maciag PC, Radulovic S, Rothman J. The first clinical use of a liveattenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix [J].Vaccine, 2009,27(30): 3975-83.
|
| 49 |
Pijkeren JP, Morrissey D, Monk IR, et al. A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy[J]. Hum Gene Ther, 2010,21(4): 405-416.
|